Treatment of Hypertriglyceridemia: a Review of Current Options
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10314389" target="_blank" >RIV/00216208:11110/15:10314389 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/15:10314389
Result on the web
<a href="http://www.biomed.cas.cz/physiolres/pdf/64/64_S331.pdf" target="_blank" >http://www.biomed.cas.cz/physiolres/pdf/64/64_S331.pdf</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Treatment of Hypertriglyceridemia: a Review of Current Options
Original language description
Hypertriglyceridemia is an important marker of increased levels of highly atherogenic remnant-like particles. The importance of lowering plasma levels of triglycerides (TG) has been called into question many times, but currently it is considered an integral part of residual cardiovascular risk reduction strategies. Lifestyle changes (improved diet and increased physical activity) are effective TG lowering measures. Pharmacological treatment usually starts with statins, although associated TG reductionsare typically modest. Fibrates are currently the drugs of choice for hyperTG, frequently in combination with statins. Niacin and omega-3 fatty acids improve control of triglyceride levels when the above measures are inadequately effective. Some novel therapies including anti-sense oligonucleotides and inhibitors of microsomal triglyceride transfer protein have shown significant TG lowering efficacy. The current approach to the management of hypertriglyceridemia is based on lifestyle chan
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FB - Endocrinology, diabetology, metabolism, nutrition
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NV15-28876A" target="_blank" >NV15-28876A: Use of HTG gene score in diagnosis of primary hypertriglyceridemias and assessment of the risk of gastrointestinal and cardiovascular complications</a><br>
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Physiological Research
ISSN
0862-8408
e-ISSN
—
Volume of the periodical
64
Issue of the periodical within the volume
Supplement 3
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
10
Pages from-to
"S331"-"S340"
UT code for WoS article
000366804200003
EID of the result in the Scopus database
2-s2.0-84952666479